The Senate will be in session this week, while the House
will have committee work with no votes scheduled.
Democrats are facing increasing pressure ahead of the midterms to
score legislative wins – particularly key components of their
agenda such as Build Back Better and an overhaul of voting rights
– which has consistently been stymied by disagreements in
their party and unforeseen emergencies, including rising gas
prices, inflation, baby formula shortages, and the war in
Ukraine.
Last Friday, a federal judge in Louisiana blocked the Biden
Administration from ending the Title 42 immigration policy. The
preliminary injunction provides an extended pause to the
Administration's plans while a lawsuit led by a multistate
coalition of Republican attorneys general is decided in the courts.
The Title 42 border restrictions were set to end today.
The conference committee that has been formed to resolve
differences in the America COMPETES Act (H.R. 4521), which aims to
boost manufacturing and technological innovation to better compete
economically with China, is already encountering contentious
negotiations. A bipartisan effort to add a tax credit for domestic
fabrication of semiconductors, known as the FABS Act, has been
opposed by some House Democrats who view the provision as aiding
large corporations. However, the credit is seen as critically
important for the semiconductor community.
Administration
President Biden is still in Japan, where he has met with Emperor
Naruhito and Prime Minister Kishida Fumio.
Senate Side
On Tuesday, the Senate will resume consideration of the nomination
of Dara Lindenbaum to be a member of the Federal Election
Commission. The chamber will also vote on the nomination of
Stephanie Dawkins Davis to be a U.S. circuit judge for the Sixth
Circuit. Senate Majority Leader Chuck Schumer (D-NY) has stated he
is considering seeking unanimous consent on a $28 million emergency
funding bill that passed the House last week. The legislation would
provide funding for the Food and Drug Administration to address the
shortage of infant formula.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.